Literature DB >> 1645903

High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.

J C Martyn1, A R Gould, B T Eaton.   

Abstract

The major core protein VP7 and a non-structural protein NS3 of bluetongue virus serotype 1 have been synthesized from recombinant plasmids using both an in vitro transcription/translation system and a yeast expression system. Bluetongue virus genes were transcribed under the control of the bacteriophage SP6 promoter and the regulatable yeast metallothionein promoter. An indirect ELISA showed that expression of NS3 in yeast was inducible with 1 mM CuSO4 and VP7 synthesis was constitutive but could be further induced. The preferred procedure for antigen extraction from yeast was sonication for VP7 and SDS/NaOH treatment for NS3. Yeast-expressed VP7 antigen and a monoclonal antibody were used in a blocking ELISA to distinguish sera raised against bluetongue virus serotypes from those generated to viruses of the epizootic haemorrhagic disease serogroup.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645903     DOI: 10.1016/0168-1702(91)90016-o

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus.

Authors:  X Wu; S Y Chen; H Iwata; R W Compans; P Roy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Evaluation of thermo-stability of bluetongue virus recombinant VP7 antigen in indirect ELISA.

Authors:  Gnanavel Venkatesan; Sanchay Kumar Biswas; Veerakyathappa Bhanuprakash; Raj Kumar Singh; Bimelendu Mondal
Journal:  Virusdisease       Date:  2015-02-10

3.  Topography and immunogenicity of bluetongue virus VP7 epitopes.

Authors:  L F Wang; A D Hyatt; P L Whiteley; M Andrew; J K Li; B T Eaton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Preparation and Characterization of a Monoclonal Antibody Against the Core Protein VP7 of the 25th Serotype of Bluetongue Virus.

Authors:  Xiao Wu; Qi Liu; Jia He; Mingxin Zang; Haixiu Wang; Yijing Li; Lijie Tang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

5.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

Authors:  M Cloete; D H du Plessis; A A van Dijk; H Huismans; G J Viljoen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Antigen capture competitive enzyme-linked immunosorbent assays using baculovirus-expressed antigens for diagnosis of bluetongue virus and epizootic hemorrhagic disease virus.

Authors:  J O Mecham; W C Wilson
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles.

Authors:  F Guirakhoo; J A Catalan; T P Monath
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

9.  Quantification of recombinant core-like particles of bluetongue virus using immunosorbent electron microscopy.

Authors:  Y Z Zheng; A Hyatt; L F Wang; B T Eaton; P F Greenfield; S Reid
Journal:  J Virol Methods       Date:  1999-06       Impact factor: 2.014

10.  A single chain Fv antibody displayed on phage surface recognises conformational group-specific epitope of bluetongue virus.

Authors:  H S Nagesha; L F Wang; B Shiell; G Beddome; J R White; R A Irving
Journal:  J Virol Methods       Date:  2001-02       Impact factor: 2.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.